MRI-Based Prediction of Vestibular Schwannoma: Systematic Review
Open Access
Abstract
Background: The vestibular schwannoma (VS) is the most common cerebellopontine angle tumor in adults, exhibiting a highly variable natural history, from stability to rapid growth. Accurate, the non-invasive prediction of tumor behavior is essential to guide personalized management and avoid overtreatment or delayed intervention. Objective: To systematically review and synthesize the evidence on MRI-based biomarkers for predicting VS growth and treatment responses. Methods: We conducted a PRISMA-compliant search of PubMed, EMBASE, and Cochrane databases for studies published between 1 January 2000 and 1 January 2025, addressing MRI predictors of VS growth. Cohort studies evaluating texture features, signal intensity ratios, perfusion parameters, and apparent diffusion coefficient (ADC) metrics were included. Study quality was assessed using the NOS (Newcastle–Ottawa Scale) score, GRADE (Grading of Recommendations, Assessment, Development and Evaluation), and ROBIS (Risk of Bias in Systematic reviews) tool. Data on diagnostic performance, including the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and p value, were extracted and descriptively analyzed. Results: Ten cohort studies (five retrospective, five prospective, total n = 525 patients) met the inclusion criteria. Texture analysis metrics, such as kurtosis and gray-level co-occurrence matrix (GLCM) features, yielded AUCs of 0.65–0.99 for predicting volumetric or linear growth thresholds. Signal intensity ratios on gadolinium-enhanced T1-weighted images for tumor/temporalis muscle achieved a 100% sensitivity and 93.75% specificity. Perfusion MRI parameters (Ktrans, ve, ASL, and DSC derived blood-flow metrics) differentiated growing from stable tumors with AUCs up to 0.85. ADC changes post-gamma knife surgery predicted a favorable response, though the baseline ADC had limited value for natural growth prediction. The heterogeneity in growth definitions, MRI protocols, and retrospective designs remains a key limitation. Conclusions: MRI-based biomarkers may provide exploratory signals associated with VS growth and treatment responses. However, substantial heterogeneity in growth definitions and MRI protocols, small single-center cohorts, and the absence of external validation currently limit clinical implementation.Keywords
This publication has 32 references indexed in Scilit:
- Emerging strategies for the prediction of behaviour, growth, and treatment response in vestibular schwannomaActa Neurochirurgica, 2025
- Hydrogels of Alginate Derivative‐Encased Nanodots Featuring Carbon‐Coated Manganese Ferrite Cores with Gold Shells to Offer Antiangiogenesis with Multimodal Imaging‐Based TheranosticsAdvanced Therapeutics, 2024
- Comparison of the Signal Intensity of Vestibular Schwannoma Between Growing and Nongrowing TumorsThe Laryngoscope, 2021
- Vestibular Schwannoma: What We Know and Where We are HeadingHead and Neck Pathology, 2020
- Prediction of transient tumor enlargement using MRI tumor texture after radiosurgery on vestibular schwannomaMedical Physics, 2020
- Texture Analysis of Standard Magnetic Resonance Images to Predict Response to Gamma Knife Radiosurgery in Vestibular SchwannomasWorld Neurosurgery, 2019
- Perfusion magnetic resonance imaging provides additional information as compared to anatomical imaging for decision-making in vestibular schwannomaEuropean Journal of Radiology Open, 2016
- ROBIS: A new tool to assess risk of bias in systematic reviews was developedJournal of Clinical Epidemiology, 2016
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurementsNeuroradiology, 2009